Gthx earnings date
WebAug 4, 2024 · Our total revenue for the second quarter of 2024 was $10.6 million, comprised of net Cosela revenue of $8.7 million and license revenue of $1.9 million compared to $6.6 million of total revenue ... WebG1 Therapeutics (GTHX) Reports Q3 Loss, Tops Revenue Estimates Zacks - Wed Nov 2, 2024. G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 7.81% and …
Gthx earnings date
Did you know?
WebApr 6, 2024 · Look out for GTHX's next earnings release expected on May 03, 2024. For the next earning release, we expect the company to report earnings of -$0.64 per share, … WebSep 30, 2024 · Current and historical p/e ratio for G1 Therapeutics (GTHX) from 2016 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation …
WebG1 Therapeutics (GTHX) reports earnings on 5/31/2024. Shares are down 32.4% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. WebFeb 27, 2024 · In the last 12 months, GTHX had revenue of $46.85 million and -$153.93 million in losses. Loss per share was -$3.60.
WebFeb 15, 2024 · February 15, 2024, 7:00 AM · 4 min read. G1 Therapeutics (GTHX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended ... WebApr 6, 2024 · G1 Therapeutics (GTHX) (Real Time Quote from BATS) $2.61 USD -0.07 (-2.61%) Updated Apr 3, 2024 12:46 PM ET Add to portfolio Zacks Rank: 2-Buy 2 Style Scores: F Value C Growth B Momentum ...
WebMar 3, 2024 · GTHX: G1 Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. GTHX: G1 Therapeutics - Detailed …
WebApr 13, 2024 · G1 Therapeutics (GTHX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 2d ago mccutchen traceWebFeb 15, 2024 · This company is expected to post quarterly loss of $0.79 per share in its upcoming report, which represents a year-over-year change of +16%. Revenues are expected to be $9.98 million, up 72.1% ... leyla harding imagesWebEarnings Preview: G1 Therapeutics (GTHX) Q1 Earnings Expected to Decline. Zacks-5.73%. Apr-21-22 08:30AM: G1 Therapeutics to Release First Quarter 2024 Financial … mccutchen t shirtmccutchen \\u0026 sexton law firmWeb23 rows · Apr 8, 2024 · Earnings for G1 Therapeutics are expected to grow in the coming year, from ($1.97) to ($1.15) ... leylah attar read onlineWebG1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates G1 Therapeutics (GTHX) delivered earnings and revenue surprises of 14.12% and 6.64%, respectively, … leylah coachWebEarnings Peers: G1 Therapeutics (GTHX) is categorized under the Healthcare sector; to help you further research next earnings dates across stocks, below are some other … mccutchen\\u0027s magnolia house scottsboro